Skip to content
Twitter page opens in new windowLinkedin page opens in new windowInstagram page opens in new window
info@pharmaust.com+61 8 9202 6814
PharmAust (PAA)
PharmAust (PAA)
  • HOME
  • ABOUT
    • Company Overview
    • PharmAust Management
    • Board
    • Corporate Directory
  • PIPELINE & TRIALS
    • Therapeutic Pipeline
    • MPL Veterinary Trial Details
    • MPL and Veterinary Trials
    • Veterinary Trial Testimonials
    • MPL and Human Trials
    • Publications
    • Pet Cancer Information Service
    • Motor Neuron Disease Trial
  • INVESTOR CENTRE
    • News & Announcements
    • Company Research
    • Financial Reports
    • Annual Reports
    • Investor Presentations
    • Corporate Governance
    • Top 20 Shareholders
  • MEDIA
    • BB PAA Video – September 2021
    • OHD Benchtop Flow Reactor Launch
    • Dr Richard Mollard – Full Interview Ticker TV – 17th June 2020
    • Interview with TechInvest – May 2020
    • Dr. Richard Mollard – 6IX Interview March 2020
    • PharmAust In the News
    • PharmAust Videos
    • PharmAust New Cancer Treatment
    • PharmAust and Catalent Commence GMP Tablet Manufacture (Audio)
    • PharmAust on Youtube
  • CONTACT
  • HOME
  • ABOUT
    • Company Overview
    • PharmAust Management
    • Board
    • Corporate Directory
  • PIPELINE & TRIALS
    • Therapeutic Pipeline
    • MPL Veterinary Trial Details
    • MPL and Veterinary Trials
    • Veterinary Trial Testimonials
    • MPL and Human Trials
    • Publications
    • Pet Cancer Information Service
    • Motor Neuron Disease Trial
  • INVESTOR CENTRE
    • News & Announcements
    • Company Research
    • Financial Reports
    • Annual Reports
    • Investor Presentations
    • Corporate Governance
    • Top 20 Shareholders
  • MEDIA
    • BB PAA Video – September 2021
    • OHD Benchtop Flow Reactor Launch
    • Dr Richard Mollard – Full Interview Ticker TV – 17th June 2020
    • Interview with TechInvest – May 2020
    • Dr. Richard Mollard – 6IX Interview March 2020
    • PharmAust In the News
    • PharmAust Videos
    • PharmAust New Cancer Treatment
    • PharmAust and Catalent Commence GMP Tablet Manufacture (Audio)
    • PharmAust on Youtube
  • CONTACT

Author Archives: Richard Mollard

UNITY Announces End to Epichem Contract

News & Announcements 2020By Richard MollardJanuary 7, 2020

200107_UNITY Announces End to Epichem Contract

31 December, Top 20 Shareholders

News & Announcements 2019By Richard MollardDecember 31, 2019

191231_Top Holders 31 December 2019

Expanded Site Recruitment for Monepantel Phase II Trial in Pet Dogs with Cancer

News & Announcements 2019By Richard MollardDecember 11, 2019

191211_expanded site recruitment

29 November, Top 20 Shareholders

News & Announcements 2019, Top 20 ShareholdersBy Richard MollardDecember 2, 2019

191130_Top_Holders_Report

Pitt Street Research Life Science Conference: Investor Presentation

Investor Presentations 2019, News & Announcements 2019By Richard MollardNovember 28, 2019

191128_Investor Presentation

Appendix 3B, Exercise of Options

Financial Reports 2019, News & Announcements 2019By Richard MollardNovember 19, 2019

191121_Exercise of Options

Appendix 3B – Exercise of Options

Financial Reports 2019, News & Announcements 2019By Richard MollardNovember 8, 2019

191108_Appendix 3B – Exercise of Options

Progress in Recruitment for Phase II Trial in Dogs

News & Announcements 2019By Richard MollardNovember 4, 2019

191104_Progress in Recruitment for Phase II Trial in Dogs

Appendix 4C and Quarterly Update

Financial Reports 2019, News & Announcements 2019By Richard MollardNovember 1, 2019

191101_Appendix 4C and Quarterly Update

31 October, Top 20 Shareholders

News & Announcements 2019By Richard MollardNovember 1, 2019

31 October_Top 20 Shareholders

1
23456789
…1011121314…
15161718192021
22
MENU
  • Home
  • About Us
  • Pipeline & Trials
  • Investor Centre
  • Media
  • Contact Us
SUBSCRIBE TO OUR NEWSLETTER

TWITTER

PharmAustFollow

PharmAust is a clinical-stage biotech company developing drug discovery IP to treat cancer, viral and neurological diseases. ASX: $PAA FSE: $ECQ

PharmAust
Retweet on TwitterPharmAust Retweeted
epichemEpichem@epichem·
29 Jun

𝐖𝐄𝐋𝐂𝐎𝐌𝐄 Fiona Milner!

Today we are rolling out the red carpet as Fiona Milner joins Epichem Pty Ltd as General Manager. The Epichem team are thrilled to have Fiona on board and we look forward to working with her.

#teamepichem

Reply on Twitter 1541992242344333312Retweet on Twitter 15419922423443333121Like on Twitter 15419922423443333125Twitter 1541992242344333312
Load More...
Copyright © 2020 Pharmaust. All rights reserved.
nil

Website Design & Digital Marketing Perth by Total Click Solutions

Go to Top